These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7513844)

  • 41. Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.
    Furuse K; Fukuoka M; Nishiwaki Y; Kurita Y; Watanabe K; Noda K; Ariyoshi Y; Tamura T; Saijo N
    J Clin Oncol; 1998 Jun; 16(6):2126-32. PubMed ID: 9626212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant human granulocyte colony-stimulating factor infusion and/or autologous peripheral blood stem cell transplantation as a rescue for sequential high-dose combination chemotherapy: a preliminary report.
    Chau WK; Lin CK; Chow MP; Wang SY; Liu JM; Ho CH; Chiu CF; Hsu HC; Tan TD; Chan WK
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):312-20. PubMed ID: 7530591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administration.
    Higa GM; DeVore RF; Auber ML; Lynch JP; Landreth KS
    Pharmacotherapy; 1998; 18(1):1-8. PubMed ID: 9469674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human recombinant granulocyte colony-stimulating factor for the treatment of autoimmune neutropenia.
    Takahashi K; Taniguchi S; Akashi K; Fujimoto K; Sibuya T; Ishibashi H; Harada M; Niho Y
    Acta Haematol; 1991; 86(2):95-8. PubMed ID: 1719726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose continuous subcutaneous infusion of granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in acute myelogenous leukemia and its pharmacokinetics.
    Ikeda K; Tasaka T; Sasaki K; Murata M; Kitanaka A; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1994 Nov; 8(11):1838-41. PubMed ID: 7526087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.
    Crawford J; George M
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):18-22. PubMed ID: 7541916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dose intensity in M-VAC chemotherapy with rG-CSF for metastatic transitional urothelial cancer].
    Obata K; Kobayashi H; Takaba H; Yokoi K; Hikosaka A
    Hinyokika Kiyo; 1994 Oct; 40(10):939-44. PubMed ID: 7527613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effectiveness of Leukostim, a Russian preparation of granulocyte colony-stimulating factor, in the treatment of chemotherapy-induced neutropenia in patients with malignant tumors].
    Korman DB; Boronovskaia LE; Maslova IA; Andreeva EV; Seregina GV
    Vopr Onkol; 2008; 54(5):639-42. PubMed ID: 19069482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer.
    Seidman AD; Scher HI; Gabrilove JL; Bajorin DF; Motzer RJ; O'Dell M; Curley T; Dershaw DD; Quinlivan S; Tao Y
    J Clin Oncol; 1993 Mar; 11(3):408-14. PubMed ID: 7680373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
    J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative effect of 100 versus 250 micrograms/m2/day of G-CSF in pediatric patients with neutropenia induced by chemotherapy.
    Kubota M; Akiyama Y; Mikawa H; Tsutsui T
    Pediatr Hematol Oncol; 1995; 12(4):393-7. PubMed ID: 7577392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protective effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) against various microbial infections in neutropenic mice.
    Matsumoto M; Matsubara S; Matsuno T; Ono M; Yokota T
    Microbiol Immunol; 1990; 34(9):765-73. PubMed ID: 1704477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful treatment of chronic idiopathic neutropenia using recombinant granulocyte colony-stimulating factor.
    Furukawa T; Takahashi M; Moriyama Y; Koike T; Kurokawa I; Shibata A
    Ann Hematol; 1991 Feb; 62(1):22-4. PubMed ID: 1709572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recombinant granulocyte colony-stimulating factor (rG-CSF) in HIV patients with zidovudine related neutropenia.
    Clumeck N; Wit SD; Hermans P; Franchioly P; Sommereijns B
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():353-6. PubMed ID: 1284305
    [No Abstract]   [Full Text] [Related]  

  • 57. [Combined effects of sizofiran and rG-CSF on myelosuppression in cancer chemotherapy].
    Hoshino T; Suzuki Y; Takeichi M; Adachi T; Takayama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Mar; 48(3):206-12. PubMed ID: 8721055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant granulocyte colony-stimulating factor (rG-CSF): pharmacoeconomic considerations in chemotherapy-induced neutropenia.
    Faulds D; Lewis NJ; Milne RJ
    Pharmacoeconomics; 1992 Apr; 1(4):231-49. PubMed ID: 10147015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of recombinant granulocyte-colony stimulating factor to treat neutropenia occurring during craniospinal irradiation.
    Mac Manus MP; Clarke J; McCormick D; Abram WP
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):845-50. PubMed ID: 7688362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Granulocyte-colony stimulating factor-induced proliferation of primary adult T-cell leukaemia cells.
    Matsushita K; Arima N; Ohtsubo H; Fujiwara H; Hidaka S; Kukita T; Suruga Y; Fukumori J; Matsumoto T; Kanzaki A; Yawata Y; Tanaka H
    Br J Haematol; 1997 Mar; 96(4):715-23. PubMed ID: 9074411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.